Double-blind placebo controlled randomized withdrawal trial assessing the efficacy and tolerability of 'on demand' maintenance therapy with 10mg o.d. rabeprazole for 6 months in non-erosive reflux disease patients with complete symptom relief after 4 week open acute phase

Trial Profile

Double-blind placebo controlled randomized withdrawal trial assessing the efficacy and tolerability of 'on demand' maintenance therapy with 10mg o.d. rabeprazole for 6 months in non-erosive reflux disease patients with complete symptom relief after 4 week open acute phase

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2007

At a glance

  • Drugs Rabeprazole (Primary)
  • Indications Gastro-oesophageal reflux; Heartburn
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top